4.6 Article

Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2010.06.115

Keywords

Gold nanoparticle; Gene delivery system; Gene knockdown; shRNA

Funding

  1. Ministry of Education, Science and Technology [20100002201]
  2. Seoul RBD program [10543, 10550]
  3. Basic Research Promotion Fund (MOEHRD) [KRF-2008-331-000171]
  4. Priority Research Centers Program through the National Research Program of Korea [2009-0093817]
  5. Korea Foundation for International Cooperation of Science & Technology (KICOS) [2008-00656]
  6. Ministry of Education, Science & Technology (MoST), Republic of Korea [2008-00656] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  7. National Research Foundation of Korea [2008-2000123, 2009-0093817, 2008-331-C00171] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

The efficient delivery of nucleic acids into mammalian cells is a central aspect of research involving cell biology and medical applications, including the clinical treatment of genetic disorders. We report an efficient small hairpin RNA (shRNA) delivery system that utilizes a single species of gold nanoparticle-DNA oligonucleotide conjugate (AuNP-DNA oligo) as a universal carrier. In vitro synthesized shRNA that is specific to the p53 gene was efficiently delivered into HEK293 and HeLa human cell lines using an AuNP-DNA oligo. The delivery resulted in an 80-90% knockdown of p53 expression. The same AuNP-DNA oligo was also efficient for the delivery of another shRNA, which is specific to the Mcl-1 gene, as well as the repression of MCL-1 expression. The knockdown efficiency of shRNA that was delivered using an AuNP-DNA oligo was comparable with that of a liposome-based shRNA delivery method. Our results offer an alternate delivery system for shRNA that can be used on any gene of interest. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available